Workflow
业绩预亏
icon
Search documents
昆仑万维:预计2025年净利润为负值
Xin Lang Cai Jing· 2026-01-30 09:03
昆仑万维公告,预计2025年度净利润为负值,预计归属于上市公司股东的净利润区间为-19.5亿元 至-13.5亿元,上年同期为-15.95亿元;扣除非经常性损益后的净利润区间为-20.48亿元至-14.48亿元,上 年同期为-16.43亿元。业绩变动主要由于公司在市场推广和研发方面持续加大投入,以及收入同比增长 超过40%,海外收入占比进一步提升。 ...
惠博普:预计2025年度净利润亏损1.5亿元~2亿元
Sou Hu Cai Jing· 2026-01-30 09:02
Group 1 - The company Huibo Pu expects a net loss attributable to shareholders of 150 million to 200 million yuan for the year 2025, with basic earnings per share loss estimated at 0.11 to 0.15 yuan [1] - In the same period last year, the company reported a net loss of approximately 191 million yuan, with a basic earnings per share loss of 0.14 yuan [1] - The main reasons for the performance change include increased foreign exchange losses due to currency fluctuations, provisions for potential additional losses related to arbitration matters in the Mexican natural gas power generation project, and impairment provisions for long-term equity investments and other assets [1] Group 2 - The nuclear power construction industry is experiencing a surge, with equipment manufacturers reporting high demand, with orders scheduled until 2028 and operations running 24 hours a day in three shifts [1]
华纺股份(600448.SH):2025年预亏2.3亿元至2.7亿元
Ge Long Hui A P P· 2026-01-30 08:57
Core Viewpoint - Huafang Co., Ltd. (600448.SH) is expected to report a significant net loss for the fiscal year 2025, with projected losses ranging from 230 million to 270 million yuan, indicating a downturn compared to the previous year [1] Financial Performance - The anticipated net profit attributable to the parent company, excluding non-recurring gains and losses, is projected to be between -228.7 million and -268.7 million yuan for 2025 [1] Reasons for Performance Decline - The primary reasons for the expected loss include: - Deterioration of the international trade environment, particularly the impact of tariff increases by certain countries, which has significantly affected the company's performance [1] - High inventory levels leading to a decrease in gross profit margin, necessitating impairment tests and the recognition of inventory write-downs [1] - Impact from national policies resulting in the shutdown of certain facilities at the company's self-owned power plant, leading to the recognition of fixed asset impairment provisions, with plans for a complete shutdown in the future [1]
华泰股份(600308.SH):2025年预亏5000万元到7000万元
Ge Long Hui A P P· 2026-01-30 08:57
Core Viewpoint - Huatai Co., Ltd. (600308.SH) is expected to report a net profit attributable to shareholders of the parent company for the year 2025 in the range of -50 million to -70 million yuan, indicating a loss compared to the previous year [1] Group 1: Financial Performance - The net profit attributable to shareholders, excluding non-recurring gains and losses, is projected to be between -125 million and -145 million yuan for 2025 [1] - The company anticipates a decline in gross profit margin due to a larger decrease in sales prices of certain products compared to the reduction in costs, resulting in operational performance fluctuations [1] Group 2: Operational Factors - The 700,000-ton pulp project is entering its initial production phase in 2025, with capacity ramp-up and process adjustments progressing normally; however, the scale effect and cost advantages of self-produced pulp have not yet fully materialized [1] - The depreciation and financial expenses related to the project will impact short-term profits after the project is capitalized [1] Group 3: Accounting Adjustments - To ensure the prudence of financial statements, the company conducted impairment tests on certain receivables and inventories in accordance with relevant accounting standards, which has affected the current period's performance [1]
大悦城:2025年预计亏损21亿-27亿元,同比减亏
Xin Lang Cai Jing· 2026-01-30 08:41
Core Viewpoint - The company anticipates a net profit loss attributable to shareholders of 2.1 billion to 2.7 billion yuan for 2025, a decrease from the previous year's loss of 2.977 billion yuan [1] Financial Performance - The expected net profit loss after deducting non-recurring items is projected to be between 2.25 billion and 2.85 billion yuan, compared to a loss of 4.05 billion yuan in the same period last year [1] - The basic earnings per share are expected to be a loss of 0.49 to 0.63 yuan per share, improving from a loss of 0.69 yuan per share in the previous year [1] Reasons for Performance - The anticipated performance decline is primarily due to the company's proactive adjustment of pricing strategies, leading to impairment signs in certain projects and the need to recognize impairment provisions [1] - The company expects a year-on-year reduction in net profit loss, mainly attributed to an increase in gross margin and investment income compared to the previous year [1]
亚士创能:2025年预亏8.3亿元—12.5亿元
Xin Lang Cai Jing· 2026-01-30 08:38
Group 1 - The company Yashichuangneng (603378) has released a performance forecast indicating an expected net profit attributable to shareholders of the parent company for the year 2025 to be between -1.25 billion and -0.83 billion yuan [1] - The decline in operating revenue and gross margin is attributed to the ongoing weakness in the real estate and construction industries, along with a significant drop in orders [1]
锐奇股份:2025年全年预计净亏损4654.04万元—6237.37万元
Core Viewpoint - Ruichi Co., Ltd. forecasts a significant net loss for the year 2025, indicating a challenging financial outlook due to rising costs and declining profit margins [1] Financial Performance Summary - The company expects a net profit attributable to shareholders to be a loss between 46.54 million and 62.37 million yuan for 2025 [1] - The projected net profit, excluding non-recurring gains and losses, is anticipated to be a loss between 65.74 million and 81.57 million yuan [1] - The impact of non-recurring gains and losses on net profit is estimated to be approximately 19.20 million yuan, compared to 21.62 million yuan in the same period last year [1] Cost and Margin Analysis - The primary reasons for the significant change in operating performance include rising raw material prices and increased operating costs [1] - There has been an increase in expenses, leading to a decline in the overall gross profit margin [1]
实丰文化:2025年业绩预亏,净利润同比降超1675%
Xin Lang Cai Jing· 2026-01-30 08:27
实丰文化公告称,2025年公司预计亏损,归属于上市公司股东的净利润亏损1.5亿元 - 1.8亿元,较上年 同期盈利952.36万元下降1675.03% - 1990.04%;扣非后净利润亏损1.15亿元 - 1.45亿元,较上年同期亏 损3163.21万元下降263.55% - 358.40%。亏损主因包括参股公司经营亏损致投资损失、海外产品质量问 题赔偿、清理滞销产品及战略转型前期投入大等。 ...
ST通脉:2025年度预计净利润亏损1.3亿至1.8亿元
Xin Lang Cai Jing· 2026-01-30 08:23
Core Viewpoint - The company expects a significant net loss for the year 2025, with projections ranging from -130 million to -180 million yuan, an improvement from the previous year's loss of -300.838 million yuan [1] Financial Performance - The anticipated non-recurring net profit for 2025 is projected to be between -125 million and -175 million yuan, compared to -237.8685 million yuan in the same period last year [1] - The decline in profitability is attributed to intense competition in the telecommunications construction industry, a decrease in gross margins, compressed project profit margins, and a high proportion of bad debt provisions for accounts receivable [1] Regulatory Issues - Due to issues related to the internal control audit report, the company's stock will continue to be subject to additional risk warnings starting from July 4, 2025 [1]
赛托生物:2025年全年预计净亏损6300万元—8800万元
Core Viewpoint - Saito Bio has announced a projected net loss for the year 2025, indicating significant financial challenges ahead due to various factors affecting its operations [1] Financial Performance - The company expects a net loss attributable to shareholders of between 63 million and 88 million yuan for the year 2025 [1] - The projected net loss, excluding non-recurring items, is anticipated to be between 66 million and 91 million yuan [1] Reasons for Performance Change - A decline in product market prices has led to a year-on-year decrease in overall gross margin, resulting in reduced gross profit [1] - As a high-tech biotechnology company focused on research and development, Saito Bio has increased its R&D expenditures, contributing to the decrease in net profit for the reporting period [1] - The company has recognized significant inventory impairment provisions for several intermediate products due to falling product prices, which has negatively impacted current profits [1]